Details for New Drug Application (NDA): 091346
✉ Email this page to a colleague
The generic ingredient in VIORELE is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
Summary for 091346
Tradename: | VIORELE |
Applicant: | Glenmark Pharms Ltd |
Ingredient: | desogestrel; ethinyl estradiol |
Patents: | 0 |
Suppliers and Packaging for NDA: 091346
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VIORELE | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 091346 | ANDA | A-S Medication Solutions | 50090-1395 | 50090-1395-0 | 1 KIT in 1 KIT (50090-1395-0) |
VIORELE | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 091346 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-318 | 68462-318-29 | 3 BLISTER PACK in 1 CARTON (68462-318-29) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.15MG,N/A;0.02MG,0.01MG | ||||
Approval Date: | Apr 2, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription